ArticleIn silico pharmacology2022

Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies.

Santosh Kumar Maurya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.